連云港杰瑞藥業(yè)有限公司成立于2004年，注冊(cè)資本1億元，是一家專業(yè)從事化學(xué)原料藥、醫(yī)藥中間體以及制劑的研發(fā)、生產(chǎn)和銷售為一體的高新技術(shù)企業(yè)。隸屬于國(guó)家重點(diǎn)高科技企業(yè)杰瑞科技集團(tuán)。

公司現(xiàn)有宋跳和大浦兩個(gè)廠區(qū)，總占地面積15萬(wàn)m2，已建成辦公大樓、研發(fā)中心、生產(chǎn)車間、倉(cāng)庫(kù)及完備配套設(shè)施。目前，公司可承接生產(chǎn)抗腫瘤原料藥、凍干粉針劑、片劑、硬膠囊劑、小容量注射劑及非抗腫瘤原料藥及中間體等。

JARI Pharmaceutical Co., Ltd., founded in 2004 with a registered capital of 100 million RMB, is a high-tech enterprise specializing in R&D, manufacturing and sales of pharmaceutical intermediates, API and formulations， and belongs to the state key high-tech enterprise JARI Technology Group.

There are two sites of JARI PHARMA, Songtiao and Dapu, covering an overall area of 150,000m2, with the constructions of office building, R&D center, production workshop, warehouse and supporting facilities. At present, our company can produce anti-cancer API, lyophilize powder for injection, tablets, hard capsules, small volume injections and non-anticancer API and intermediates.